Hematopoietic cell transplantation can be lifesaving, but it’s also one of the most demanding treatments patients and families will ever face.
ASTCT’s Palliative and Supportive...
by Chelsea Honstain, MS, FNP-C
ASTCT’s Clinical Education Conference will take place Sept. 29-30 in Fort Worth, Texas. Conference attendees will learn about the latest trends in stem cell transplantation and...
by Sita Bhella, MD, MEd, FRCPC
Immune effector cell-associated neurotoxicity syndrome is a complication of chimeric antigen receptor T-cell therapy. The condition is characterized by neurologic symptoms, such as tremors,...
by Jayne Kramer
A new blog post from Jayne Kramer spotlights ASTCT’s upgraded Practice Guidelines mobile app — now featuring a modern interface, enhanced diagnostic tools and improved navigation.
by Randy Taplitz, MD, FIDSA
Non-Aspergillus invasive mold infections (NAIMIs) are rare but often life-threatening complications for stem cell transplant recipients. A new ASTCT clinical practice guideline outlines best...
by Randy Taplitz, MD, FIDSA
A new blog post from Dr. Phuong T. Vo highlights two groundbreaking trials that are reshaping treatment options for patients with severe aplastic anemia — especially those without fully...